| 1 · GPCStaphylococci |
S. aureus S. epidermidis S. saprophyticusGP cocci in irregular grape-like clusters; non-motile, non-sporing; usually non-capsulated |
- Catalase + (differentiates from Strep)
- S. aureus: coagulase +, DNase +, catalase +, ferments mannitol, gelatin liquefaction +
- Blood agar: β-hemolysis, yellow/clear zones
- Nutrient agar: golden yellow colonies (endopigment), best at RT
- Mannitol salt agar (7.5% NaCl): yellow colonies; selective
- CoNS: coagulase −; S. saprophyticus novobiocin-resistant; S. epidermidis novobiocin-sensitive
|
S. aureus cell-wall components- Peptidoglycan: elicits IL-1, opsonic Abs; PMN chemoattractant; endotoxin-like; activates complement
- Teichoic acids: antigenic; part of phage receptors
- Protein A: binds Fc of IgG except IgG₃; Fab free → "coagglutination" reagent
- Capsule (some strains): polysaccharide, antiphagocytic unless specific Abs present
- Phage surface receptors: phage typing
- Fibronectin-binding proteins (FnBPs): adhesion/invasion
|
Enzymes- Catalase; Coagulase (clots citrated plasma, fibrin coat → resists phagocytosis); Clumping factor (binds fibrinogen non-enzymatically, distinct from coagulase); hyaluronidase, staphylokinase, proteinases, lipases, β-lactamase
Toxins- Enterotoxin (A–E, G–I, K–M): superantigen, heat-resistant, acid/enzyme-resistant → food poisoning (vomiting>diarrhea)
- TSST-1: superantigen → toxic shock (tampons, wound, nasal packing); 5–25% isolates; blood cultures typically negative
- Exfoliative toxins A & B: proteases dissolving epidermal mucopolysaccharide → SSSS
- Leukocidins: α (necrosis, hemolysis), β, δ
- PVL: bicomponent (S+F); severe necrotizing pneumonia in children; CA-MRSA (phage-encoded)
Pigment- Staphyloxanthin: carotenoid, antioxidant evading ROS; golden color
|
- Specimens by site: blood, pus swab, CSF, urine, vomitus/stool/food
- Direct smear: GPC in grape-like clusters among pus cells
- Culture: β-hemolysis blood agar + golden colonies; mannitol salt agar for contaminated samples
- ID tests: catalase, coagulase, DNase, mannitol fermentation, gelatin liquefaction
- Phage typing: epidemiologic tracing (hospital outbreaks; food handlers' nose/nailbed/fomites)
- Routine AST; molecular typing; serology of little value
- Food poisoning: vomitus/stool/food remnants; mannitol salt agar; demonstrate enterotoxin by gel diffusion
|
- ~90% produce β-lactamase → Pen-G resistant; susceptible to β-lactamase-resistant penicillins (methicillin, oxacillin), cephalosporins, vancomycin
- MRSA (~20%): altered PBPs → DOC vancomycin
- Newer: linezolid, daptomycin, quinupristin/dalfopristin
- S. epidermidis: vancomycin + rifampicin or gentamicin
- Prevention: handwashing, asepsis; intranasal mupirocin for nasal carriage; remove shedders from OR/newborn nurseries
|
- ~20% humans are long-term nasal carriers of S. aureus
- S. epidermidis: most important cause of prosthetic valve endocarditis (biofilm/glycocalyx); CSF shunt infections; neonatal sepsis; peritoneal dialysis peritonitis; hospital-acquired
- S. saprophyticus: 2nd commonest community UTI in sexually active young women (within 24h post-coitus)
- CA-MRSA (PVL+) molecularly distinct from HA-MRSA; CA-MRSA: homeless, IVDU, athletes
- Right-sided (tricuspid) endocarditis in IVDU
- HA-MRSA causes ~50% of nosocomial S. aureus infections
- SSSS: young children; recovery 7–10d; hair/nails may slough
- Staph food poisoning IP 1–8h (preformed toxin in carbohydrate-rich foods, milk products)
|
| 1 · GPCStreptococci |
S. pyogenes (Gp A) S. agalactiae (Gp B) Viridans group S. pneumoniaeGP cocci in chains; oxidase & catalase NEG; facultative anaerobes; many require enriched media |
- Oxidase & catalase negative
- Hemolysis: β (pyogenes, agalactiae), α (viridans, pneumoniae), γ (bovis)
- S. pyogenes: bacitracin-sensitive
- S. agalactiae: CAMP +, hydrolyzes hippurate, NOT bacitracin-sensitive, SXT-resistant, double-zone hemolysis
- Viridans vs pneumoniae: bile insoluble vs soluble; inulin non-fermenter vs fermenter; optochin resistant vs sensitive; mouse non-pathogenic vs pathogenic; Quellung − vs +
- Better growth in 5–10% CO₂
|
S. pyogenes- M protein: >150 types; antiphagocytic; rheumatogenic & nephritogenic strains; Abs protective
- Hyaluronic acid capsule: antiphagocytic, non-immunogenic
- Lipoteichoic acid: covers pili; mucosal adherence
- Fibronectin-binding protein: adherence + internalization
- C-carbohydrate: Lancefield grouping (A–W, no I/J)
S. agalactiae- Capsular polysaccharide (classification)
S. pneumoniae- ≥90 capsular serotypes; types 1–8 → 75% adult pneumonia; serotyped by Quellung
- C-polysaccharide (CPS): cell-wall PS common to all pneumococci
|
S. pyogenes — Enzymes- Streptokinase (fibrinolysin) — lyses thrombi; used clinically for MI
- DNase A–D; anti-DNase B for pyoderma dx
- Hyaluronidase — "spreading factor"
S. pyogenes — Toxins- Pyrogenic exotoxin A (erythrogenic): phage-encoded superantigen → STSS, scarlet fever
- Pyrogenic exotoxin B: protease → necrotizing fasciitis ("flesh-eating")
- Pyrogenic exotoxin C → STSS
- Streptolysin O: O₂-labile, antigenic → ASO titer for RF dx
- Streptolysin S: O₂-stable, non-antigenic; β-hemolysis on plate
- C5a peptidase, neuraminidase, serum opacity factor
S. pneumoniae- Capsule (antiphagocytic, inhibits C3b opsonization)
- Pneumolysin (Ply): 53-kDa pore-forming, activates complement
- Autolysin (LytA): lyses bacteria, releases pneumolysin
- H₂O₂: damages host cells; bactericidal vs H. influenzae
- Pili: URT colonization, induce TNF → septic shock
- CbpA / PspA: adhesin, inhibits complement opsonization
|
- Specimens: swabs, pus, blood (bacteremia)
- Gram stain; Ag detection (ELISA, agglutination)
- Blood agar, 37°C, 5–10% CO₂; bacitracin disc (GpA); CAMP test (GpB)
- Latex agglutination for serogrouping
- Post-strep dz: ASO ≥1/200; CRP (latex w/ anti-CRP); ESR (RF triad ASO+CRP+ESR); anti-DNase B ≥80 U for AGN
- S. pneumoniae: sheep blood ± gentamicin, 5–10% CO₂; sputum/CSF Gram; PS Ag detection (latex, ELISA); CPS ELISA in sputum; PCR (autolysin, pneumolysin); immune-complex assay; Quellung serotyping (reference labs)
|
- S. pyogenes: penicillin DOC; erythromycin if allergic
- RF prevention: prompt Pen for GAS throat; recurrence prevention with monthly benzathine penicillin for several years
- S. pneumoniae: penicillin (resistance now prevalent, usually multi-drug); new cephalosporins, fluoroquinolones effective; vancomycin best; routine AST
Pneumococcal vaccines- 23-valent polysaccharide: ≥65y, chronic illness 2–64y, immunocompromised; 0.5 mL ID/IM; ≥5y protection
- 7-valent conjugate: all children at 2, 4, 6 mo + 12–15 mo; selected 24–59 mo
- Passive Ig for immunodeficient children; chemoprophylaxis for asplenic children
|
- M types: rheumatogenic 1, 2, 5, 6, 18; nephritogenic 2, 4, 12, 49, 59–61; impetigo 49, 57, 59–61
- ARF: 1–4 wk post-throat; anti-M cross-reacts with heart; common, recurrent; long-acting Pen prophylaxis; dx ASO/CRP/ESR; damages valves & myocardium
- AGN: 3 wk post-skin; Ag-Ab complex on GBM; less common, non-recurrent; dx anti-DNase B; majority recover
- S. agalactiae: most important cause of neonatal infections; 10–40% females are vaginal carriers; chains appear as paired cocci
- Viridans (S. mutans): dental caries; SBE on damaged valves via dextran synthesis from glucose adhering to fibrin-platelet aggregates
- Necrotizing fasciitis: M types 1, 3 + exotoxins A & B (superantigen)
- S. pneumoniae: lancet-shaped GP diplococci, encapsulated; α-hemolytic
- Pneumococcal risk: extremes of age, cirrhosis, DM, asplenia (sickle), CSF leak, daycare <2y
- Scarlet fever: strawberry tongue, sore throat, sunburn rash (host lacks antitoxin)
|
| 1 · GPCEnterococci |
E. faecalis E. faeciumGP cocci in short chains; formerly Streptococcus (split 1984); >17 species |
- Facultative anaerobes; grow 10–45°C
- Ordinary media; usually non-hemolytic
- PYR + and Voges-Proskauer +
- H₂S production; reduction of litmus milk
- Grow in 6.5% NaCl broth; bile esculin +
|
— (textbook does not specify) |
- Gelatinase: protease (gelatin, collagen, peptides)
- Hemolysin: cytolytic — lyses human, horse, rabbit RBC
- Biofilm / Enterococcal Surface Protein (ESP): adhesion to bladder epithelium in UTI
- Extracellular superoxide: enhances E. faecalis survival with B. fragilis
|
- Specimens by site: urine, blood, pus
- Culture: blood agar, MacConkey, CLED (urine), bile esculin, 6.5% NaCl broth
- Blood culture for bacteremia/endocarditis
- ID: morphology, Gram, biochem, PYR+, VP+, H₂S, litmus milk reduction
|
- Intrinsic + acquired resistance; usually resistant to penicillins & aminoglycosides
- VRE: major nosocomial pathogen, difficult to treat
- VRE options: quinupristin/dalfopristin (synercid), linezolid, daptomycin, tigecycline
|
- Normal intestinal flora of humans & animals; feared nosocomial pathogens
- Diseases: UTI, endocarditis, bacteremia, catheter-related, surgical wounds, intra-abdominal & pelvic
- Infecting strains often originate from patient's own gut flora
- Genitourinary instrumentation often precedes enterococcal endocarditis
|
| 3 · Non-spore GPBCorynebacterium |
C. diphtheriaeDiphtheroids: C. ulcerans, C. pseudotuberculosis (non-lipophilic); C. jeikeium, C. urealyticum (lipophilic); Propionibacterium acnes (anaerobic) |
- GP rod, clubbed ends, pleomorphic, non-sporing
- Chinese letter (acute angles) or palisade (parallel)
- Beaded with methylene blue (metachromatic volutin granules)
- Aerobic/facultative anaerobic; Loeffler's serum at 37°C
- Blood tellurite: grey-black; 4 biotypes — gravis, mitis, intermedius, belfanti
- Oxidase + and catalase +
|
— (textbook describes only toxin antigenicity) |
- Diphtheria toxin (DT):
- Gene on lysogenic bacteriophage; non-lysogenized strains = non-pathogenic
- Production controlled by repressor DtxR (iron-responsive)
- A-B fragments; B binds receptor; A ADP-ribosylates EF-2 → inhibits protein synthesis
- C. diphtheriae itself uses a different protein (not EF-2)
- Heat-labile, highly antigenic; formalin → toxoid (antigenicity retained)
|
- Diagnosis is clinical initially — do NOT delay antitoxin
- Specimen: swab from pseudomembrane / skin lesion
- Smears: Gram (Chinese letter/palisade); methylene blue (beaded)
- Culture: Loeffler's serum + blood tellurite
- Toxigenicity tests (reference labs):
- Elek's test (immunoprecipitation w/ antitoxin paper)
- PCR for tox gene
- ELISA
- Immunochromatographic assay (rapid, highly sensitive)
- Tissue culture monolayer overlay
- Carriers: throat swab
|
- Diphtheria antitoxin: 20,000–100,000 U IM/IV after hypersensitivity skin/conjunctival test; only neutralizes circulating toxin
- Antimicrobials: penicillin or erythromycin — arrest toxin production
- Supportive care
- Contacts: DT booster + erythromycin or long-acting Pen; antitoxin NOT indicated
Prevention- Diphtheria toxoid (0.3% formalin; adsorbed onto Al(OH)₃ / Al phosphate as adjuvants)
- DTP/DTaP at 2, 4, 6, 18 mo + school-age booster; adults Td q10y (no pertussis after 6y → encephalopathy)
- Hexavalent (DTP-HBV-HIB-Polio) available
|
- Disease via local + systemic DT effects (organism has little invasive capacity)
- Pseudomembrane: necrotic epithelium + fibrin + RBC/WBC over tonsils/pharynx/larynx; bleeds if pulled
- Distant toxic damage: myocarditis (CHF, arrhythmia), nerve paralysis (soft palate, eye muscles, extremities — reversible)
- IP 2–4d; tonsillar (droplet) commonest; cutaneous (direct contact, fomites) rare
- C. ulcerans: may carry tox gene → diphtheria-like
- C. jeikeium: immunocompromised, bacteremia, high mortality, multi-resistant
- C. urealyticum: urease+, alkaline urine + crystals, slow grower, multi-resistant UTI
- Propionibacterium acnes: anaerobic, pathogenesis of acne
|
| 3 · Non-spore GPBListeria |
L. monocytogenesShort GP rod, non-sporing; resembles diphtheroids on smear; blends features of Coryne & Strep |
- Catalase + (distinguishes from Strep)
- Tumbling motility at 22°C, NOT at 37°C
- Blood agar: small colony with narrow β-hemolysis
- "Cold enhancement": grows well at refrigeration temperatures
|
— |
- Internalin: binds host E-cadherin → endocytic uptake
- Listeriolysin O (LLO): pore-forming → escapes phagosome to cytosol
- Bacterial phospholipases (phagosome escape)
- Actin rockets: actin filament propels bacteria cell-to-cell
- Immunity primarily cell-mediated
|
- Specimens by site: CSF, blood, stool
- Direct smear: GP rods resembling diphtheroids
- Culture: small grey colonies + narrow β-hemolysis on blood agar
- ID: Gram, tumbling motility, catalase +
|
- DOC: ampicillin + gentamicin (fulminant cases, T-cell compromise)
- Alternative: ampicillin + TMP-SMX
- Resistant strains rare
- Gastroenteritis: no treatment usually needed
|
- Infections primarily in fetus/newborn (transplacental or during delivery) & pregnant women + immunosuppressed (renal transplant, AIDS, lymphoma)
- Newborn meningitis 1–4 wk post-delivery via bacteremia
- Primarily an animal pathogen; transmission via contaminated unpasteurized milk/cheese, vegetables, undercooked meats (chicken, hot dogs)
- Gastroenteritis: watery diarrhea, fever, headache, myalgias, cramps, little vomiting
- Refrigerator storage of contaminated food increases gastroenteritis risk
|
| 2 · Spore-forming GPBBacillus |
B. anthracis B. cereusLarge rectangular GP bacilli in long chains; B. anthracis non-motile, capsulated; oval central spores in vitro |
- Aerobic, grow at 37°C
- B. anthracis nutrient agar: rounded, opaque, grey-white, ground-glass with comma projections — "Medusa head"
- Blood agar: non-hemolytic
- Gelatin stab: "inverted fir tree" (longest lateral spikes near surface)
- B. cereus: β-lactamase producer
|
- B. anthracis: unique — only bacterium with a protein capsule (poly-D-glutamic acid); gene on plasmid pXO2; antiphagocytic
|
B. anthracis — Tripartite exotoxin (pXO1)- Edema Factor (EF): A subunit, adenyl cyclase → ↑cAMP → ↓PMN function, massive edema
- Protective Antigen (PA): receptor binding, channel for EF/LF entry into phagocytes
- Lethal Factor (LF): protease; with PA = lethal toxin; stimulates macrophage release of TNF-α, IL-1β
- Both plasmids critical
B. cereus toxins- Emetic toxin: heat-stable, reheated rice, IP 1–5h
- Diarrheal toxin: heat-labile, meat/sauces, IP 8–24h
|
- High-risk pathogen: BSC, gloves, mask; chemical fixation (heat does not kill)
- Specimens: vesicle fluid, exudate, sputum, stools, blood
- Smears:
- Gram: large GP rods in chains
- Polychrome methylene blue (in-vivo capsule): pink rim around blue bacillus → McFadden's reaction
- Modified ZN (0.5% H₂SO₄): spores stain pink (environmental)
- IF for rapid dx
- Culture: Medusa head colonies, non-hemolytic, inverted fir tree; Gram + spore stain
- Animal inoculation: IP mice/guinea pigs
- Indirect HA + ELISA for confirmation
- PCR for bioterrorism
- B. cereus: stool ≥10⁵/g of incriminated food (usually not done)
|
- B. anthracis: ciprofloxacin or doxycycline; early prophylaxis crucial for inhalation
- B. cereus: resistant to penicillin (β-lactamase); doxycycline, erythromycin, ciprofloxacin
Control/prevention (anthrax)- AVA (BioThrax): from avirulent, non-encapsulated strain; adsorbed onto Al(OH)₃; IM deltoid at 0, 4 wks; boost 6, 12, 18 mo; annual
- Burn/deep-bury carcasses in lime; autoclave animal products; double-bag contaminated materials; live attenuated animal vaccines
|
- Anthrax: primarily disease of herbivores (goats, sheep, cows); humans incidental
- Spores resistant to drying, heat, UV, disinfectants — survive decades in soil
- Routes:
- Cutaneous (commonest) → "malignant pustule": painless black eschar with edema rim
- Pulmonary (wool-sorters' disease): NOT pneumonia — mediastinal hemorrhage + bloody pleural effusion; ~100% lethal
- GI: rare; vomiting, abdominal pain, bloody diarrhea
- Spore size 1–2 μm = ideal alveolar penetration → ideal bioterrorism agent
- B. cereus also opportunistic: post-traumatic endophthalmitis, endocarditis, osteomyelitis, pneumonia
- B. cereus emetic: nausea, vomiting, ± diarrhea, self-limited 24h; diarrheal: profuse watery, vomiting uncommon
|
| 2 · Spore-forming GPBClostridium |
C. botulinum C. tetani C. perfringens C. difficileNatural habitat: soil & intestinal tract of animals/humans |
- Anaerobes
- C. tetani: drumstick appearance (terminal spore)
- C. perfringens: hemolytic anaerobic blood agar; Nagler's reaction (visible precipitate around colonies on egg-yolk media — lecithinase)
- ID by morphology, sugar fermentation, Nagler's; C. tetani also by gas-liquid chromatography
|
— |
C. botulinum- Botulinum toxin: very potent neurotoxin; blocks ACh release from presynaptic terminals (autonomic + motor end plate) → flaccid paralysis
C. tetani- Tetanospasmin: blocks release of inhibitory neurotransmitters (GABA, glycine) → muscle overactivity → tetanic spasm
C. perfringens- α-toxin (lecithinase): degrades lecithin → cell lysis
- θ (theta) toxin: hemolytic, necrotic
- Proteases, DNases, hyaluronidase, collagenases — liquefy tissue, spread
- Enterotoxin: heat-labile, produced in meat dishes → hypersecretion in jejunum/ileum
C. difficile- Toxin A: enterotoxin → watery diarrhea
- Toxin B: cytotoxin → pseudomembrane formation
|
- C. botulinum:
- Adult: toxin in leftover food + patient serum by passive HA or RIA
- Infant: toxin in bowel contents, NOT serum
- C. tetani: clinical + history; lab generally unhelpful — wound aspirate for GP drumstick bacilli; anaerobic culture + GLC
- C. perfringens: myonecrosis/cellulitis clinical; deep exudate for large GP rods; anaerobic blood agar (hemolytic, Nagler's reaction)
- C. difficile: colonoscopy (red mucosa + white pseudomembrane); stool ELISA/latex for toxins A & B
|
C. botulinum- Adult: immediate antitoxin + intubation/ventilation
- Infant: hospitalization + supportive
C. tetani — 3 patient categories- Past immunized, last booster >10y → another booster
- Never immunized → booster + human TIG
- Active disease → human TIG + booster + wound cleaning/excision + penicillin + muscle relaxants + respiratory support
C. perfringens- Immediate removal of foreign material + devitalized tissue + O₂ exposure
- Hyperbaric O₂ + penicillin + metronidazole
C. difficile- Discontinue initial antibiotic + oral metronidazole or vancomycin
Tetanus prevention- Toxoid in DPT at 2, 4, 6, 18 mo; boost 4–6y; boosters q10y
|
- Botulism — classic adult: smoked fish, home-canned vegetables → bilateral cranial nerve palsies, diplopia, dysphagia, descending paralysis, respiratory failure
- Infant botulism: fresh honey → constipation → swallowing difficulty → "floppy baby"
- Tetanus: spores in soil + horse/animal feces; puncture wound, burn, umbilical stump, surgical sutures; non-invasive; trismus (lockjaw) → risus sardonicus → tonic spasm; death from respiratory mechanical failure
- C. perfringens: gas gangrene — moist spongy cracking skin (gas pockets); clostridial myonecrosis: edematous, foul-smelling, dark, crepitus; clostridial endometritis after incomplete abortion / unsterile instruments
- C. difficile: 3% general / 30% hospitalized carriers; feco-oral via hospital staff hands; precipitated by fluoroquinolones, macrolides, clindamycin, β-lactam/inhibitor, all cephalosporins; profuse mucoid greenish malodorous watery stools + cramps + fever; onset 5–10 days post-Ab (range 1d to 10 wks after cessation)
|
| 9 · GNCNeisseria |
N. gonorrhoeae (Gonococci) N. meningitidis (Meningococci)Commensals: N. mucosa, N. sicca, N. flavescens; GN kidney-shaped cocci in pairs, intra-/extracellular in pus; type-IV pili (twitching motility); meningococci capsulated |
- All Neisseria: oxidase + and catalase +
- N. gonorrhoeae: glucose only (acid)
- N. meningitidis: glucose + maltose (acid)
- Commensal Neisseria: variable sugar fermentation
- Strict aerobe; better in moist atmosphere + 5–10% CO₂ at 37°C × 24h
- Enriched media: chocolate agar & Modified Thayer-Martin (MTM) — vancomycin + colistin + nystatin + SXT
- Carbohydrate utilization = principal basis for commercial rapid ID
|
N. gonorrhoeae- Pili (type IV — twitching motility): mucosal attachment
- Surface proteins: attachment
- LOS (lipooligosaccharide): highly branched, no repeating O-Ag
- IgA proteases: cleave secretory IgA
- Epithelial endocytosis: vacuolar evasion
N. meningitidis- Capsular polysaccharide: 13 serogroups; A, B, C, Y, W-135 important; A & C epidemic, B sporadic, A common in Africa; antiphagocytic
- Outer membrane proteins: class 1, 2, 3 → serotyping; role in internalization
- Pili (type IV): main adhesion + internalization
- LPS: endotoxin → septic shock, hemorrhage (RBC destruction)
- IgA protease
|
- (Antigens above act as virulence factors)
- Gonococcal antigenic heterogeneity + antigenic variation of pili/surface proteins → repeated infections common
- Gonococcal infection is superficial → IgG poorly protective; secretory IgA destroyed by IgA proteases
|
Gonorrhea — males acute- Urethral discharge; Gram = GN diplococci intra-/extracellular in pus cells (diagnostic)
Chronic males / females (acute & chronic)- Specimen: chronic male — morning drop, centrifuged urinary deposit, prostatic fluid post-massage; female — urethral & cervical discharge
- Gram smear: difficult (flora / low number)
- Culture: chocolate or MTM at 37°C, 5–10% CO₂; ID by microscopy + biochem; carbohydrate utilization most sensitive
- Recent: DFA, Gonotest (cross-reactions), DNA probe, ELISA
- Non-venereal: conjunctival, synovial fluid, blood — same lines
Meningococcal meningitis — CSF- Physical: turbid, under tension
- Cells > 20,000/mm³, PMN predominant
- Centrifuge → Gram + chocolate agar culture
- CSF Ag detection: latex agglutination, coagglutination (Staph CoA + anti-meningococcal Ab), counter-IEP, Quellung, DFA
- Blood culture; PCR for CSF/blood DNA
- Carriers: West's nasopharyngeal swab → MTM
|
- Gonorrhea: ceftriaxone DOC; co-treat for Chlamydia (tetracycline or azithromycin) — 50% co-infection
- Prevention: condoms; treat partners; erythromycin ointment for ophthalmia neonatorum prevention
- Meningococcal meningitis: medical emergency — IV penicillin G or ceftriaxone immediately (sometimes pre-LP); 7–10d; chloramphenicol if resistant
- Chemoprophylaxis (close contacts): rifampicin 600 mg PO BID × 2d OR ciprofloxacin (oral/IM) — secreted in saliva
Meningococcal vaccines- MCV4: conjugate (A/C/Y/W-135 + diphtheria toxoid carrier); 2–55y
- MPSV4: polysaccharide; only one licensed for >55y
- Group B polysaccharide not included — poorly immunogenic
|
- N. meningitidis infects humans only: cannot obtain iron other than from transferrin/lactoferrin
- Normal nasopharyngeal flora 5–30% adults; up to 70–80% during epidemics
- Only bacterial meningitis known to occur in epidemics; most common 2–18 y
- Meningococcemia: high fever, hemorrhagic rash, DIC, collapse
- Gonococci fragile: susceptible to temperature, drying, UV
- Female gonorrhea: ~80% asymptomatic; vagina not infected in adults (acidity + flora + stratified squamous); rectal up to 40%
- Repeated gonococcal infections common (antigenic heterogeneity + pilus/surface variation + superficial → little IgG protection + IgA protease)
- Ophthalmia neonatorum: cornea → blindness; vulvovaginitis in young females (vagina = simple squamous; via towels/seats)
- Disseminated gonococcal: hemorrhagic papules/pustules, tenosynovitis/arthritis, endocarditis, meningitis
- PID → infertility, ectopic pregnancy
|
| 4 · EnterobacteriaceaeEscherichia |
E. coliGN bacilli, usually motile, some capsulated; major facultative bowel anaerobe; family: facultative anaerobes, MacConkey-growing, oxidase NEG, nitrate-reducers, ferment glucose |
- Lactose fermenter — rose-pink on MacConkey
- Ferments glucose, lactose, maltose, mannitol, sucrose, salicin with acid + gas
- IMViC: + + − − (indole+, MR+, VP−, citrate−)
|
- O (somatic) — cell-wall LPS
- H (flagellar)
- K (capsular) in capsulated strains
|
Diarrheagenic E. coli- Pili (colonization factor): epithelial attachment
- Enterotoxins LT & ST (ETEC): LT A-B → A subunit activates adenylate cyclase → ↑cAMP → Cl secretion + Na inhibition (cholera-like); ST → ↑guanylate cyclase → cGMP → fluid loss
- Shiga toxin / verotoxin (EHEC, STEC): modifies 28S rRNA → blocks protein synthesis
Uropathogenic E. coli- Fimbrial adhesins, hemolysins (exotoxins), K antigen
LPS- Endotoxin → endotoxic shock
|
- Specimens: feces, urine, wound, respiratory, blood, CSF
- Direct detection useful only in normally sterile sites (CSF — agglutination for K1 antigen in neonatal meningitis)
- Culture: MacConkey + blood agar @ 37°C; blood culture for septicemia/meningitis; CLED quantitatively for urine
- ID: morphology, Gram, oxidase, biochem; slide agglutination with specific antisera; tissue culture for toxin (ETEC, EHEC) / invasiveness (EIEC) / adherence (EPEC, EaggEC); ELISA for toxins; DNA probe or PCR for toxin genes
|
- Guide by in-vitro susceptibility (resistant strains emerging)
- Diarrhea: rehydration + electrolyte correction; selected antibiotics if needed
|
- Normal bowel flora — provides colonization resistance; indicator of fecal pollution of water (with E. faecalis, C. perfringens)
- UTI — most common cause: >80% community; ascending → urethritis, cystitis, pyelitis, pyelonephritis; hospital UTI usually catheter + multi-resistant
- Neonatal meningitis: E. coli K1 common cause
- Pneumonia, sepsis, septicemia, endotoxic shock (esp. neonates)
- Diarrheagenic pathotypes:
- ETEC: severe diarrhea in infants/children & traveler's diarrhea
- EHEC / STEC: bloody diarrhea / hemorrhagic colitis; HUS; O157:H7 commonest; ground beef outbreaks; STECs: O26, O111, O103, O121, O45, O145
- EPEC: infantile diarrhea — tight adherence, interferes with absorption
- EIEC: Shigella-like, no Shiga toxin
- EaggEC: persistent diarrhea in children; O104:H4 Germany 2011 (vegetables) — acquired Shiga genes → HUS
|
| 4 · EnterobacteriaceaeKlebsiella |
K. pneumoniae K. ozaenae K. rhinoscleromatis K. oxytocaNon-motile, usually capsulated GN bacilli; environment + intestinal/respiratory mucosa |
- MacConkey: rose-pink, mucoid colonies (slime)
- Ferments glucose, lactose, maltose, mannitol, sucrose, salicin with acid + gas
- K. pneumoniae IMViC: − − + +
- Non-motile
|
- 77 serotypes based on capsular polysaccharide
|
- Capsule — most important virulence factor
|
- Morphology, mucoid colonies, biochem
|
- Intrinsically resistant to ampicillin
- ESBL (extended-spectrum β-lactamase) — resistance to most effective cephalosporins
- Routine AST required
|
- Community & nosocomial:
- UTI (most common)
- Lobar pneumonia
- Wound & bloodstream infections with focal lesions (liver/lung abscess)
- Neonatal sepsis: septicemia, meningitis
- K. ozaenae → atrophic rhinitis
- K. rhinoscleromatis → rhinoscleroma (destructive granuloma of nose & pharynx)
- Multi-drug-resistant nosocomial strains prevail in hospitals
|
| 4 · EnterobacteriaceaeCitrobacter, Enterobacter, Serratia |
Citrobacter Enterobacter SerratiaMotile GN bacilli; soil/water/occasionally human respiratory & intestinal tracts |
- Motile lactose fermenters
- Citrobacter: like E. coli but citrate positive
- Enterobacter: like Klebsiella but motile
- Serratia: some strains red non-diffusible pigment — used for testing efficiency of bacterial filters
|
— | — | — | — |
- Opportunistic infections similar to K. pneumoniae
|
| 4 · EnterobacteriaceaeProteus |
P. vulgaris P. mirabilis Morganella morganii Providencia rettgeriGN pleomorphic, motile, non-sporing bacilli; soil, sewage, feces |
- Simple & enriched media; concentric wavy "swarming" growth
- Non-lactose fermenters
- Urease positive
|
- P. vulgaris OX-10, OX-2, OX-K: share antigenic similarity with Rickettsiae → Weil-Felix reaction
|
— |
- Isolation by morphology, swarming, biochem (urease)
|
- According to AST — resistant to many antimicrobials
|
- Diseases: UTI, wound infection, otitis media
- Weil-Felix reaction = key principle for rickettsial serodiagnosis
|
| 4 · EnterobacteriaceaeSalmonella |
S. typhi (Gp D) S. paratyphi A/B/C S. typhimurium S. enteritidis S. choleraesuisGN bacilli, motile, non-capsulated (S. typhi carriers acquire Vi antigen) |
- MacConkey: pale yellow, NLF
- Glucose, maltose, mannitol → acid only (S. typhi), acid + gas (S. paratyphi)
- H₂S + in S. typhi & S. paratyphi B & C
- Indole − and urease −
|
- O (somatic), H (flagellar), Vi (capsular)
|
- Pili: host-cell adherence
- Two pathogenicity islands; contact secretion system
- Facultative intracellular in macrophages
- Vi antigen: retards PMN phagocytosis
|
- Wk 1: blood + bone marrow culture; Wk 2+: stool + urine culture
- Serology: Widal — 4-fold rise diagnostic; ≥1/160 in Egypt
- Carriers: high anti-Vi titer
|
- Chloramphenicol, ampicillin, TMP-SMX, FQs, 3rd-gen cephalosporins
- Carriers: ampicillin, TMP-SMX, ciprofloxacin ± cholecystectomy
|
- Enteric fever: endemic Egypt; M cells → Peyer's patches → bacteremia → secondary bacteremia + fever; gallbladder stones favor carriage
- Food poisoning (S. typhimurium): IP 12–48h; no blood invasion
|
| 4 · EnterobacteriaceaeShigella |
S. dysenteriae (Gp A) S. flexneri (Gp B) S. boydii (Gp C) S. sonnei (Gp D)GN bacilli, non-motile, non-capsulated; strict human pathogens |
- MacConkey/DCA: pale yellow NLF
- S. sonnei: late lactose fermenter
- Anaerogenic; H₂S − and urease −
|
- Lacks H antigen; 4 serogroups by O antigen
|
- Invasiveness: large plasmid; contact secretion system
- Shiga exotoxin (S. dysenteriae type I): enterotoxic, cytotoxic, neurotoxic
- Endotoxin (LPS)
|
- Stool (blood + mucus); selenite broth → MacConkey/DCA
- Latex agglutination
|
- Fluid & electrolyte replacement
- Ampicillin, ciprofloxacin, 3rd-gen cephalosporins
|
- Infectious dose ~100 organisms; "4 Fs": flies, feces, fingers, food
- Dysentery triad: cramps, tenesmus, bloody mucoid stools
|
| 5 · Non-ferm GNBPseudomonas |
P. aeruginosaAerobic, non-spore-forming, motile, non-fermentative GN bacilli; ubiquitous in moist hospital environments |
- Non-fermentative; oxidase + and catalase +
- Grows at 42°C
- Diffusible exopigments: pyoverdin + pyocyanin → bright green
- Grape-like odor
|
— |
- Pili, flagella; Endotoxin; Biofilm formation
- Exotoxin A: ADP-ribosylates EF-2 (like DT)
- Elastase & phospholipase; Exoenzyme S
|
- Culture readily; ID by morphology + pigment + biochem
- Bacteriophage typing for epidemiology
|
- Multi-resistant → in-vitro testing required
- Serious infections: β-lactam + aminoglycoside
|
- Community: folliculitis, swimmer's ear, corneal ulcer (contact lens), osteomyelitis (IVDU)
- Nosocomial: ICU respiratory, UTI, wound, CF chronic lung infection
|
| 5 · Non-ferm GNBAcinetobacter |
A. baumanniiWidely distributed in soil/water; hospital environment |
- GN coccobacilli; oxidase NEGATIVE — differentiates from Neisseria/Moraxella
|
— | — |
- Mistaken for N. meningitidis — oxidase NEGATIVE distinguishes
|
- Often multi-resistant; susceptibility testing required
|
- Nosocomial pneumonia (most common); bacteremia from IV catheters
|
| 5 · Non-ferm GNBMoraxella |
M. catarrhalis M. lacunata |
- GN bacilli/coccobacilli; non-motile, non-fermentative
- Oxidase + and DNase +
|
— |
- M. catarrhalis: β-lactamase producer
|
- Distinguished from Neisseria by DNase positivity
|
- Penicillin EXCEPT M. catarrhalis (β-lactamase)
|
- M. catarrhalis: otitis media + LRT infection
- M. lacunata: angular conjunctivitis + blepharitis
|
| 6 · Curved GNBVibrios |
V. cholerae O1 & O139 V. parahaemolyticus V. vulnificusComma-shaped GN rods; saprophytes in surface water and soil |
- Comma-shaped; single polar flagellum, darting motility
- Alkaline pH 8.5–9.5; TCBS: V. cholerae yellow; V. parahaemolyticus green
- Oxidase +, indole +
- Cholera red reaction +; String test +
|
- O1: Ogawa, Inaba, Hikojima; biotypes Classical & El Tor
- O1 & O139 → epidemic cholera
|
- TCP: colonization pilus
- Cholera toxin (CT): phage-encoded; activates adenylate cyclase → ↑cAMP → massive Cl⁻/Na⁺/water secretion
- Mucinase
|
- Rice-water stools → alkaline peptone water → TCBS
- Agglutination with anti-O1 and anti-O139 sera; PCR for CT gene
|
- IV fluids — most important
- Tetracycline (shortens excretion)
|
- IP 1–4d; rice-water diarrhea; up to 20 L/day fluid loss
- V. parahaemolyticus: gastroenteritis from seafood; TCBS green
|
| 6 · Curved GNBCampylobacter |
C. jejuni (95%) C. coli C. fetusSpiral, motile, GN, microaerophilic |
- Comma-, S-, gull-wing-shaped; microaerophilic + capnophilic
- Thermophilic — 42°C optimal
- Skirrow's medium; oxidase + catalase +; urease NEGATIVE
|
— |
- Invasiveness; enterotoxin; CDT
|
- Stool; Skirrow's at 42°C × 2–4d; 1% basic fuchsin stain
|
- Erythromycin or ciprofloxacin (severe)
|
- Zoonotic; unpasteurized milk, poultry
- Complications: Guillain-Barré syndrome, reactive arthritis
|
| 6 · Curved GNBHelicobacter |
H. pyloriMultiple polar SHEATHED flagella |
- Similar to Campylobacter but Skirrow's at 37°C, 1 week
- Urease POSITIVE — key difference from Campylobacter
|
— |
- Urease; Adhesins; VacA; CagA
|
- Invasive: rapid urease test, histology, culture
- Non-invasive: urea breath test, stool ELISA, PCR, serology
|
- Triple therapy: metronidazole + bismuth + amoxicillin/tetracycline × 14d
- Alternative: PPI + amoxicillin + clarithromycin/metronidazole × 1 wk
|
- >50% world population colonized
- Peptic ulcer, chronic gastritis, MALT lymphoma, gastric adenocarcinoma
|
| 7 · Fastidious GNBHaemophilus |
H. influenzae (Hib most pathogenic) H. ducreyi H. aegyptius H. parainfluenzae |
- Need factor X (hemin) + factor V (NAD) → chocolate agar
- Satellite phenomenon around S. aureus
- Catalase + and oxidase +
|
- Types a–f; Hib most pathogenic; most normal-flora strains non-typable
|
- IgA protease; PRP capsule (Hib); OMP + LPS
|
- Chocolate agar 37°C 5% CO₂; satellite phenomenon
- Latex agglutination (LAT) for type-b PS in CSF
- PCR most sensitive
|
- Cefotaxime or ceftriaxone
- Meningitis: steroids 15–20 min before antibiotic
- H. ducreyi: macrolide + ceftriaxone
|
- Hib: meningitis, acute epiglottitis, septic arthritis, cellulitis (5 mo to 5 y)
- H. ducreyi: chancroid — painful genital ulcer; increases HIV risk
- H. aegyptius: purulent conjunctivitis + Brazilian purpuric fever
|
| 7 · Fastidious GNBBordetella |
B. pertussis B. parapertussis |
- Bordet-Gengou or charcoal blood agar; "mercury drop" colonies
|
— |
- PT; AC toxin; TCT; FHA + pertactin (adhesion)
|
- Saline nasal wash; direct IF; PCR most sensitive
|
- Erythromycin DOC
- DTaP vaccine
|
- Phases: catarrhal (infectious) → paroxysmal (whoop + vomiting + cyanosis)
- Complications: pneumonia, cerebral hemorrhage
|
| 7 · Fastidious GNBBrucella |
Br. melitensis (most virulent) Br. abortus (needs 8–10% CO₂) Br. suis Br. canis |
- GN short coccobacilli; slow growers (blood cultures 1 month)
- BSC required; catalase + oxidase +; urease +
|
- 2 LPS antigens A and M; immunity mainly cell-mediated
|
- Facultative intracellular parasite; LPS endotoxic; L antigen
|
- Blood cultures (repeated); STAT ≥1/100; prozone avoided by dilutions; Coombs for blocking IgA; ELISA; PCR
|
- Tetracycline + (streptomycin OR rifampicin)
- No human vaccine; pasteurization
|
- Undulant fever; endemic Egypt; transmission: intestinal, mucous membranes, skin
- Localize in reproductive organs → sterility & abortion in animals
|
| 7 · Fastidious GNBFrancisella |
F. tularensis |
- GN coccobacillus; modified Thayer-Martin agar
|
— | — |
- Strict lab precautions (highly infectious)
|
- Streptomycin or gentamicin × 10d; live attenuated vaccine for lab workers
|
- Reservoir: rabbits, rodents; ticks; tularemia; dangerous bioweapon
|
| 8 · Yersinia / PasteurellaYersinia |
Y. pestis (plague) Y. enterocolitica Y. pseudotuberculosis |
- Y. pestis: NLF; bipolar staining; non-motile; better at 27–30°C
- Y. enterocolitica: urease +, motile at 25°C, non-motile at 37°C; cold enrichment
|
- F1 capsular antigen; V-W antigens (virulent strains)
|
- LPS; F1 antigen; V-W antigens; YOPs (inhibit phagocytosis); exotoxin
|
- Y. pestis: DFA; PCR; culture at 27–30°C; BSC always
- Y. enterocolitica: cold enrichment → MacConkey at 25°C
|
- Y. pestis: ciprofloxacin, doxycycline, gentamicin; formalin-killed vaccine
- Yersiniosis: doxycycline + aminoglycoside
|
- Plague: bubonic/septicemic/pneumonic; rat-flea cycle; bioterrorism agent
- Y. enterocolitica: children; may mimic appendicitis
|
| 8 · Yersinia / PasteurellaPasteurella |
P. multocida |
- Non-motile GN coccobacilli with bipolar staining; oxidase + catalase +
|
— | — |
- Standard culture from wound discharges
|
— |
- Most common organism in cat/dog bites or scratches; cellulitis, osteomyelitis, arthritis
|
| 10 · AnaerobesBacteroides |
B. fragilisPredominant anaerobe in human colon |
- Slim, pale-staining, capsulated GN rods; strict anaerobe
|
— |
- Superoxide dismutase; polysaccharide capsule → abscess formation; LPS less toxic; collagenase, fibrinolysin, heparinase
|
|
- Drainage + debridement; almost always β-lactamase producers
- Clindamycin, metronidazole; imipenem; clavulanate/sulbactam combinations
|
- Endogenous from patient's own gut; peritonitis + intra-abdominal abscess
- Spreads to blood more than any other anaerobe
|
| 10 · Anaerobes / ActinomycetesActinomycetes |
Actinomyces israelii (anaerobic) Nocardia asteroides (aerobic) Streptomyces Actinomadura madurae |
- Aerobic species: partially acid-fast, beaded branching filaments
- Anaerobic species (Actinomyces): GP branching filaments; anaerobic culture × 2 weeks
|
— | — |
- Actinomycosis: sulfur granules; GP branching filaments + radiating GN clubs
- Nocardia: GP, partially acid fast
|
- Actinomycosis: surgical drainage + penicillin G 6–12 mo
- Nocardiosis: TMP-SMX
|
- Actinomycosis: cervicofacial, thoracic, abdominal forms; sulfur granules in pus
- Nocardiosis: frequently misdiagnosed as TB; brain abscess
- Mycetoma: swelling + sinuses draining granules; feet of farmers without shoes
|
| 11 · Atypical GNBLegionella |
L. pneumophila |
- Fastidious aerobic GN; poorly stained with Gram; BCYE agar
|
— |
- Inhibition of phagosome-lysosome fusion; C3b coating
|
- BCYE aerobic; urinary antigen by ELISA (fastest); PCR; serology
|
- Macrolides or fluoroquinolones
- Prevention: hyperchlorination + heating of water supplies
|
- No person-to-person spread; aerosols from A/C + shower heads
- Legionnaire's disease (pneumonia) vs Pontiac fever (mild flu)
|
| 11 · Minor pathogensBartonella |
B. bacilliformis B. quintana B. henselae |
- Small GN, polymorphic, motile bacilli
|
— | — | — |
- B. bacilliformis: penicillin, streptomycin, chloramphenicol
- B. henselae: supportive ± tetracycline/erythromycin
|
- B. bacilliformis: Oroya fever (sand flies)
- B. quintana: Trench fever (body lice)
- B. henselae: Cat-scratch disease (2 wk post-scratch)
|
| 11 · Minor pathogensGardnerella |
G. vaginalis |
- Gram variable coccobacilli
|
— | — |
- "Whiff" test (KOH → fishy odor); clue cells; vaginal pH ≥ 4.5
|
|
- Bacterial vaginosis; premature rupture of membranes, preterm labor
|
| 12 · MycobacteriaMycobacterium |
M. tuberculosis + M. bovis (MTC) M. leprae Atypicals: MAC, M. kansasii, M. scrofulaceum, M. marinum, M. fortuitum |
- Acid fastness due to mycolic acids
- M. tb: resists 25% H₂SO₄; M. leprae: 5% H₂SO₄
- Slow growers; obligate aerobes
- Lowenstein-Jensen, Middlebrook 7H10/7H9, BACTEC
- Never reported negative before 8 wks
|
— |
- Glycolipids → granuloma formation; intracellular survival
- No exotoxin, no endotoxin
|
- ZN + auramine stain; culture = gold standard; PCR
- Latent: Mantoux ≥10 mm or IGRA (not affected by BCG)
- M. leprae: NOT culturable; lepromin test
|
- TB: INH + RIF + PZA + EMB/SM × 6–12 mo
- MDR-TB: resistant ≥ INH + RIF; XDR-TB: MDR + FQ + ≥3 second-line
- Leprosy: dapsone + rifampicin × 2 years
- BCG: first year of life; also for bladder carcinoma
|
- 1/3 world infected; 90% destroy; 10% active disease
- Primary (Ghon's) → secondary (reactivation: upper lobes, cavitation, miliary)
- Lepromatous (leonine facies, lepromin −) vs Tuberculoid (anesthesia, lepromin +)
|
| 13 · SpirochetesTreponema |
T. pallidum |
- Not cultivable; microscopy + serology only
|
— |
- Outer membrane proteins (adherence); hyaluronidase
|
- Dark-ground microscopy; Silver (Fontana); Direct IF; PCR
- Non-specific STS: VDRL, RPR; Specific: FTA-ABS, MHA-TP (remain + for life)
|
- Penicillin; tetracycline/erythromycin if allergic
|
- Primary: nontender chancre (50% serology negative)
- Secondary: maculopapular rash incl. palms/soles, condylomata lata
- Tertiary: gummas, aortitis, CNS
- Congenital: Hutchinson's teeth, saddle nose, interstitial keratitis
|
| 13 · SpirochetesBorrelia |
B. burgdorferi (Lyme) B. recurrentis (epidemic RF) B. duttoni (endemic RF) |
|
— | — |
- Lyme: ELISA + Western immunoblot
- Relapsing fever: Leishman/Giemsa blood films; mouse inoculation in afebrile phase
|
- Tetracyclines and penicillin
|
- Lyme: "bull's eye" ECM; myocarditis; arthritis (immune complex)
- Epidemic RF (lice, B. recurrentis, human reservoir) vs Endemic RF (tick bite)
- ANUG (Vincent's): polymicrobial, immunocompromise (HIV)
|
| 13 · SpirochetesLeptospira |
L. interrogans |
- Culture on Fletcher's or Stuart's medium at 30°C
|
— | — |
- Blood (during fever), urine (from week 2)
- Serology: agglutination + ELISA from week 2
|
- Penicillin and tetracyclines
|
- Reservoir: rats; contact with animal urine in water
- Weil's disease: jaundice + hemorrhages + renal failure ± meningitis
- Occupational: sewage workers, farmers, fishermen
|
| 14 · MycoplasmaMycoplasma |
M. pneumoniae M. hominis U. urealyticum M. genitalium |
- No rigid cell wall (sterols in membrane); completely resistant to penicillin
- Fried-egg colonies ≥1 wk
- Cold agglutinins: titer >1/128 positive (50%)
|
— | — |
- Serology most useful: IgM or rising IgG (ELISA/CFT); cold agglutinin ≥1/128
- IF for Ag; PCR/DNA probes
|
- Tetracyclines or macrolides
|
- M. pneumoniae: atypical pneumonia
- U. urealyticum: NGU; lung disease in low-birth-weight premature infants
|
| 15 · RickettsiaRickettsia & Coxiella |
Typhus: R. prowazekii, R. typhi, O. tsutsugamushi Spotted: R. rickettsii, R. akari Coxiella burnetii |
- Non-motile GN; obligate intracellular
- Coxiella: endospore-like structure → heat/UV/drying resistant
|
- Coxiella: Phase I (infectious, nature) vs Phase II (avirulent)
- Weil-Felix cross-reactivity with P. vulgaris OX strains
|
- Vasculitis via intracellular multiplication in endothelial cells
|
- Initial diagnosis clinical — do NOT delay treatment
- IFA, CF, ELISA; 4-fold rise diagnostic
- Brill-Zinsser: rapid early IgG (vs IgM in primary typhus)
|
- Doxycycline DOC; chloramphenicol
|
- Epidemic typhus (lice, human reservoir); centrifugal rash; Brill-Zinsser = latent reactivation
- Endemic typhus (rat flea); RMSF: centripetal rash (ankles/wrists → trunk/face)
- Q fever: pneumonia + granulomatous hepatitis, NO rash; chronic → endocarditis
|
| 16 · ChlamydiaChlamydiaceae |
C. trachomatis (A–C, D–K, L1–L3) C. psittaci C. pneumoniae |
- Obligate intracellular; 250–400 nm; no peptidoglycan
- EB (infectious, extracellular) → RB (replicating, intracellular) → EB
- McCoy cells (trachomatis/psittaci); HEP-2 cells (pneumoniae)
|
- Group-specific LPS; strain-specific OMPs; ≥15 serotypes
|
— |
- Cytoplasmic inclusion bodies: Giemsa, iodine, fluorescent Ab stain
- Ag by ELISA or IF; PCR; cell culture with iodine stain for inclusion bodies
|
- Tetracycline or erythromycin
- STD: doxycycline or azithromycin; treat partners
- C. psittaci: quarantine imported birds
|
- A–C: Trachoma (leading preventable infectious blindness)
- D–K: NGU, PID, inclusion conjunctivitis, neonatal pneumonia
- L1–L3: LGV → genital elephantiasis
- C. psittaci: psittacosis (pet parrots), atypical pneumonia
- C. pneumoniae: atypical pneumonia; possibly associated with atherosclerosis
|